Once fu­ri­ous over No­var­tis’ da­ta ma­nip­u­la­tion scan­dal, the FDA now says it’s noth­ing they need to take ac­tion on

Back in the BP era — Be­fore Pan­dem­ic — the FDA ripped No­var­tis for its de­ci­sion to keep the agency in the dark about ma­nip­u­lat­ed da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.